CS1001
CS1001/Regorafenib-101
Phase 2 small_molecule completed
Quick answer
CS1001 for Advanced Refractory Solid Tumors is a Phase 2 program (small_molecule) at Cstone Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cstone Pharmaceuticals Ireland Limited
- Indication
- Advanced Refractory Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed